Department of Gastroenterology, Graduate school of Medicine, the University of Tokyo, Tokyo, Japan.
Department of Gastroenterology, Graduate school of Medicine, the University of Tokyo, Tokyo, Japan; Department of Gastroenterology, The Institute for Adult Diseases, Asahi-life Foundation, Tokyo, Japan.
Gastroenterology. 2020 May;158(6):1650-1666.e15. doi: 10.1053/j.gastro.2020.01.046. Epub 2020 Feb 4.
BACKGROUND & AIMS: Gastric chief cells, a mature cell type that secretes digestive enzymes, have been proposed to be the origin of metaplasia and cancer through dedifferentiation or transdifferentiation. However, studies supporting this claim have had technical limitations, including issues with the specificity of chief cell markers and the toxicity of drugs used. We therefore sought to identify genes expressed specifically in chief cells and establish a model to trace these cells.
We performed transcriptome analysis of Mist1-CreERT-traced cells, with or without chief cell depletion. Gpr30-rtTA mice were generated and crossed to TetO-Cre mice, and lineage tracing was performed after crosses to R26-TdTomato mice. Additional lineage tracing experiments were performed using Mist1-CreERT, Kitl-CreERT, Tff1-Cre, and Tff2-Cre mice crossed to reporter mice. Mice were given high-dose tamoxifen or DMP-777 or were infected with Helicobacter pylori to induce gastric metaplasia. We studied mice that expressed mutant forms of Ras in gastric cells, using TetO-Kras, LSL-Kras, and LSL-Hras mice. We analyzed stomach tissues from GPR30-knockout mice. Mice were given dichloroacetate to inhibit pyruvate dehydrogenase kinase (PDK)-dependent cell competition.
We identified GPR30, the G-protein-coupled form of the estrogen receptor, as a cell-specific marker of chief cells in gastric epithelium of mice. Gpr30-rtTA mice crossed to TetO-Cre;R26-TdTomato mice had specific expression of GPR30 in chief cells, with no expression noted in isthmus stem cells or lineage tracing of glands. Expression of mutant Kras in GPR30 chief cells did not lead to the development of metaplasia or dysplasia but, instead, led to a reduction in labeled numbers of chief cells and a compensatory expansion of neck lineage, which was derived from upper Kitl clones. Administration of high-dose tamoxifen, DMP-777, or H pylori decreased the number of labeled chief cells. Chief cells were eliminated from epithelia via GPR30- and PDK-dependent cell competition after metaplastic stimuli, whereas loss of GRP30 or inhibition of PDK activity preserved chief cell numbers and attenuated neck lineage cell expansion.
In tracing studies of mice, we found that most chief cells are lost during metaplasia and therefore are unlikely to contribute to gastric carcinogenesis. Expansion of cells that coexpress neck and chief lineage markers, known as spasmolytic polypeptide-expressing metaplasia, does not occur via dedifferentiation from chief cells but, rather, through a compensatory response from neck progenitors to replace the eliminated chief cells.
胃主细胞是一种成熟的细胞类型,能够分泌消化酶,它通过去分化或转分化被认为是化生和癌症的起源。然而,支持这一说法的研究存在技术局限性,包括主细胞标志物特异性的问题和药物毒性问题。因此,我们试图鉴定在主细胞中特异性表达的基因,并建立一种追踪这些细胞的模型。
我们对 Mist1-CreERT 标记的细胞进行了转录组分析,这些细胞有或没有主细胞耗竭。生成了 Gpr30-rtTA 小鼠,并将其与 TetO-Cre 小鼠杂交,在与 R26-TdTomato 小鼠杂交后进行了谱系追踪。使用 Mist1-CreERT、Kitl-CreERT、Tff1-Cre 和 Tff2-Cre 小鼠与报告小鼠杂交,进行了额外的谱系追踪实验。给小鼠高剂量他莫昔芬或 DMP-777,或感染幽门螺杆菌诱导胃化生。我们使用 TetO-Kras、LSL-Kras 和 LSL-Hras 小鼠研究了在胃细胞中表达突变型 Ras 的小鼠。我们分析了 GPR30 敲除小鼠的胃组织。给小鼠二氯乙酸以抑制丙酮酸脱氢酶激酶(PDK)依赖性细胞竞争。
我们发现,G 蛋白偶联雌激素受体的 GPR30 是小鼠胃上皮主细胞的特异性标志物。与 TetO-Cre;R26-TdTomato 杂交的 Gpr30-rtTA 小鼠在主细胞中特异性表达 GPR30,而在峡部干细胞中没有表达,也没有谱系追踪到腺体。突变型 Kras 在 GPR30 主细胞中的表达不会导致化生或发育不良的发生,而是导致标记的主细胞数量减少,以及源自上 Kitl 克隆的颈部谱系的代偿性扩张。高剂量他莫昔芬、DMP-777 或 H pylori 的给药减少了标记的主细胞数量。在化生刺激后,主细胞通过 GPR30 和 PDK 依赖性细胞竞争从上皮中消除,而 GPR30 或 PDK 活性的丧失则保留了主细胞数量并减弱了颈部谱系细胞的扩张。
在对小鼠的追踪研究中,我们发现大多数主细胞在化生过程中丢失,因此不太可能导致胃癌的发生。表达颈部和主细胞谱系标志物的细胞的扩张,即舒张多肽表达的化生,不是通过主细胞的去分化发生的,而是通过颈部祖细胞的代偿性反应来替代被消除的主细胞。